chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) male or female patients aged between 40 and 80 years; 2) according to the GOLD standard, the pulmonary function was classified as GOLD2-4; 3) stable phase of COPD (discharge > 3 weeks); 4) voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) pregnant women; 2) patients with severe organ insufficiency (heart failure, liver failure, renal failure); 3) patients with severe pulmonary vesicles; 4) patients with severe thoracic and abdominal aortic aneurysms; 5) patients with advanced malignant tumor; 6) patients with pneumothorax and pneumothorax within 1 month after healing; 7) patients with unstable angina pectoris and recent myocardial infarction; 8) patients with severe hypertension and hypertensive crisis; 9) those who are unable to cooperate with or affect their activities (such as long-term bedridden, severe malnutrition, arterial disease of lower extremities, recent fractures or major thoracic and abdominal surgery, hemiplegia, facial paralysis, cerebrovascular accidents, myasthenia gravis, mental illness, cerebral palsy and mental retardation). 10) hemoptysis within two weeks; 11) patients with open pulmonary tuberculosis and all patients with infectious diseases; 12) patients with gastrointestinal bleeding in active stage; 13) patients with indwelling gastric tube; 14) patients with tracheotomy; 15) patients with severe thoracic and spinal deformities; 16) other active diseases that may affect the results of the study; 17) situations where other doctors do not consider it appropriate to join a study or perform respiratory rehabilitation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Readmission rate or number of acute exacerbations / 3 months;Quality of life (SGRQ); | — |
Secondary
| Measure | Time frame |
|---|---|
| Activity ability (6-minute walking distance);Symptoms (CAT score, MMRC);Accuracy and compliance of patients using inhaled drugs;To verify the effectiveness of each module process of respiratory rehabilitation management platform for community patient rehabilitation management.; | — |
Countries
china
Contacts
North Campus, China-Japan Friendship Hospital